Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/15457
Appears in Collections:Aquaculture Journal Articles
Peer Review Status: Refereed
Title: Production and efficacy of an Aeromonas hydrophila recombinant S-layer protein vaccine for fish
Author(s): Poobalane, Saravanane
Thompson, Kimberly
Ardo, Laszlo
Verjan, Noel
Han, Hyun-Ja
Jeney, Galina
Hirono, Ikuo
Aoki, Takashi
Adams, Alexandra
Contact Email: alexandra.adams@stir.ac.uk
Keywords: Aeromonas hydrophila
Recombinant S-layer protein vaccine
Efficacy testing
Common carp
Aeromonas hydrophila
Fishes Diseases Vaccines
Issue Date: Apr-2010
Date Deposited: 12-Jun-2013
Citation: Poobalane S, Thompson K, Ardo L, Verjan N, Han H, Jeney G, Hirono I, Aoki T & Adams A (2010) Production and efficacy of an Aeromonas hydrophila recombinant S-layer protein vaccine for fish. Vaccine, 28 (20), pp. 3540-3547. https://doi.org/10.1016/j.vaccine.2010.03.011
Abstract: A recombinant protein for the S-layer protein of Aeromonas hydrophila was produced and its ability to protect common carp Cyprinus carpio L. against six virulent isolates of A. hydrophila was assessed. A group of 120 carp (30-40 g) were vaccinated intra-peritoneally with 0.1 ml of adjuvanted vaccine (30 μg protein per fish). Another group of 120 carp were injected with 0.1 ml of PBS-adjuvant mixture to serve as controls. Twenty fish from each group were challenged with each one of six virulent isolates of A. hydrophila 35 days post-vaccination. The fish were maintained in 12 separate tanks before terminating the experiment at 16 days post-challenge. The relative percentage survival (RPS) for the six isolates of A. hydrophila ranged from 56 to 87%. The difference in survival rate of fish challenged with four of the isolates was statistically significant in vaccinated fish compared to control fish, when analysed using a Chi-square test. The results of the study suggest that the recombinant S-layer protein of A. hydrophila could be useful as a vaccine antigen to protect fish against different isolates of this pathogenic bacterium.
DOI Link: 10.1016/j.vaccine.2010.03.011
Rights: The publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.
Licence URL(s): http://www.rioxx.net/licenses/under-embargo-all-rights-reserved

Files in This Item:
File Description SizeFormat 
vaccine 2010.pdfFulltext - Published Version764.3 kBAdobe PDFUnder Permanent Embargo    Request a copy

Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependent on the depositor still being contactable at their original email address.



This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.